Tyra Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 10.42 M | $244.89 M | 0.00% | 17.69% |
BOXER CAPITAL, LLC | 11/14/2024 | 6.45 M | $151.60 M | 0.00% | 10.95% |
BVF INC/IL | 11/14/2024 | 4.66 M | $109.58 M | 0.00% | 7.92% |
CANAAN PARTNERS XI LLC | 10/16/2024 | 4.41 M | $103.68 M | 0.00% | 7.49% |
NEXTECH INVEST LTD. | 11/14/2024 | 4.06 M | $95.35 M | 0.00% | 6.89% |
FMR LLC | 11/13/2024 | 3.37 M | $79.30 M | 0.78% | 5.73% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 1.99 M | $46.76 M | 0.00% | 3.38% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.52 M | $35.65 M | 100.00% | 2.58% |
VANGUARD GROUP INC | 11/13/2024 | 1.25 M | $29.28 M | 0.56% | 2.12% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.07 M | $24.99 M | 100.00% | 1.81% |
5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 939,298 | $22.08 M | 0.00% | 1.60% |
ORBIMED ADVISORS LLC | 11/14/2024 | 768,638 | $18.07 M | 0.00% | 1.31% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 731,020 | $17.19 M | -12.16% | 1.24% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 523,190 | $12.30 M | 0.10% | 0.89% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 511,226 | $12.02 M | -49.25% | 0.87% |
KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 467,947 | $11.00 M | -17.43% | 0.79% |
SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 400,870 | $9.42 M | -33.22% | 0.68% |
STATE STREET CORP | 11/14/2024 | 384,732 | $9.05 M | 4.41% | 0.65% |
JPMORGAN CHASE & CO | 11/08/2024 | 368,647 | $8.67 M | 1.07% | 0.63% |
ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 270,075 | $6.35 M | 2.05% | 0.46% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 248,800 | $5.85 M | 100.00% | 0.42% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 200,000 | $4.70 M | 100.00% | 0.34% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 173,737 | $4.08 M | 2.23% | 0.30% |
JENNISON ASSOCIATES LLC | 11/08/2024 | 158,187 | $3.72 M | 5.92% | 0.27% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 150,000 | $3.53 M | 255.26% | 0.25% |
WALLEYE CAPITAL LLC | 11/14/2024 | 126,597 | $2.98 M | 306.46% | 0.22% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 115,616 | $2.72 M | -39.33% | 0.20% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 90,825 | $2.14 M | -22.39% | 0.15% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 89,081 | $2.09 M | -22.45% | 0.15% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 88,100 | $2.07 M | 100.00% | 0.15% |
OPPENHEIMER & CO INC | 11/05/2024 | 76,806 | $1.81 M | 8.96% | 0.13% |
MORGAN STANLEY | 11/14/2024 | 68,916 | $1.62 M | 6.80% | 0.12% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 67,500 | $1.59 M | 100.00% | 0.11% |
WOODLINE PARTNERS LP | 11/14/2024 | 55,866 | $1.31 M | -36.99% | 0.09% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 54,353 | $1.28 M | 9.77% | 0.09% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 49,998 | $1.18 M | -46.04% | 0.08% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 42,999 | $1.01 M | -74.75% | 0.07% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 42,786 | $1.01 M | -26.34% | 0.07% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 39,176 | $921,028 | 11.07% | 0.07% |
BARCLAYS PLC | 11/19/2024 | 37,625 | $884,000 | 200.54% | 0.06% |
STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 35,566 | $836,157 | -6.57% | 0.06% |
D. E. SHAW & CO., INC. | 11/14/2024 | 32,003 | $752,391 | 100.00% | 0.05% |
JANE STREET GROUP, LLC | 11/15/2024 | 31,003 | $728,881 | -24.38% | 0.05% |
VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 30,080 | $707,181 | -36.22% | 0.05% |
TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 26,346 | $619,394 | 100.00% | 0.04% |
SWISS NATIONAL BANK | 11/07/2024 | 25,700 | $604,207 | 100.00% | 0.04% |
RHUMBLINE ADVISERS | 11/12/2024 | 25,175 | $591,856 | 6.80% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 23,952 | $563,112 | 100.00% | 0.04% |
CINCTIVE CAPITAL MANAGEMENT LP | 11/14/2024 | 22,900 | $538,379 | 100.00% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 21,600 | $507,816 | 100.00% | 0.04% |
Tyra Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of Tyra Biosciences, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.42 M
Boxer Capital, LLC: 6.45 M
BVF INC/IL: 4.66 M
Canaan Partners XI LLC: 4.41 M
Nextech Invest Ltd.: 4.06 M
FMR LLC: 3.37 M
79.92% of Tyra Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 48.21 M shares in the last 24 months. This purchase volume represents approximately $679.24 M in transactions.